After a disappointing phase 1 showing, Janux Therapeutics is kicking one of its bispecific T-cell engagers (TCEs) ...
Insulin resistance is a common extrahepatic manifestation of hepatitis C virus (HCV) infection (HCVi), but its mechanism is poorly understood. While ...
Data, generated in the lab of Dr. Amir Horowitz of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, demonstrated that ...
The U.S. Food and Drug Administration has broadened approval of Teplizumab-developed by Sanofi-to include children as young ...
Empowered by Pipeline and Forged by Technology: Mabwell Successfully Lists on the Main Board of HKEX
Reportedly, founded in 2017, Mabwell is a leading domestic innovative pharmaceutical enterprise, possessing premier innovative drug R&D capabilities and end-to-end whole-industry-chain capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results